Glaxo Group, Ltd.
MS. Abraham 100/C.882-C.897
Bodleian Libraries, University of Oxford
-
Details
-
This item is described in 1 online catalogue.?
For the main catalogue entry, see: Bodleian Archives & Manuscripts
Description
From Bodleian Archives & Manuscripts
This is an extract only. For more information, see the catalogue record in Bodleian Archives & Manuscripts.
Bodleian Archives & Manuscripts contains descriptions of the Bodleian Libraries’ archival collections, including post-1500 manuscripts. Some manuscripts with records in other catalogues are also described here as part of a description of a larger archive. Learn more.
Title
Glaxo Group, Ltd.
Shelfmark
MS. Abraham 100/C.882-C.897
Summary
In 1956 the NRDC arranged for Glaxo to join in the research on Cephalosporin C, chiefly to find ways of increasing the yields of the antibiotic from strains of the cephalosporium fungus. This was achieved after much painstaking work involving repeated mutations of the mould. Glaxo's huge investment in the research bore fruit in 1964, with the introduction of its drug 'Ceporin' ('cephaloridine') into medicine.
C.882-C.889: Correspondence regarding cephalosporin nomenclature, 1957-1964.
C.890-C.897: Included at C.891 and C.892 are a draft and a later copy of the script of a Glaxo film entitled 'Antibiotic from the sea'. Abraham assisted in the production of the script and appeared in the film, though not as a speaker. Also included is correspondence regarding the Conference on Cephalosporidine at New College Oxford, 13-16 March 1967, which Abraham attended; at C.895 is a copy of a typescript of an introductory talk given by Abraham at the conference entitled 'Cephaloridine. Historical Remarks'.
Date
1957-1968
Language
English
Physical extent
16 folders
View full record in Bodleian Archives & Manuscripts
Collection contents
Archive of Sir Edward Penley Abraham
Research
Other organisations
Glaxo Group, Ltd.
See this item
-
Requesting
-
For information on how to request this item, see Bodleian Archives & Manuscripts.